tradingkey.logo
搜索

Clarivate PLC

CLVT
添加自选
1.980USD
-0.025-1.24%
收盘 07-31 16:00美东报价延迟15分钟
1.27B总市值
亏损市盈率 TTM

关于 Clarivate PLC 公司

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.

Clarivate PLC简介

公司代码CLVT
公司名称Clarivate PLC
上市日期Oct 29, 2018
CEOTov (Matitiahu Shem)
员工数量12000
证券类型Ordinary Share
年结日Oct 29
公司地址70 St. Mary Axe
城市LONDON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United Kingdom
邮编EC3A 8BE
电话442074334000
网址https://clarivate.com/
公司代码CLVT
上市日期Oct 29, 2018
CEOTov (Matitiahu Shem)

Clarivate PLC公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Kenneth L. Cornick
Mr. Kenneth L. Cornick
Director
Director
1.21M
+0.88%
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
677.02K
+32.63%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
357.32K
+10.97%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
231.66K
-8.59%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
170.60K
+31.70%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
160.71K
+36.65%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+36.67%
Mr. Anthony Munk
Mr. Anthony Munk
Lead Independent Director
Lead Independent Director
--
--
Mr. Jane Okun Bomba, CPA
Mr. Jane Okun Bomba, CPA
Independent Director
Independent Director
--
--
Mr. Usama N. Cortas
Mr. Usama N. Cortas
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Kenneth L. Cornick
Mr. Kenneth L. Cornick
Director
Director
1.21M
+0.88%
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
677.02K
+32.63%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
357.32K
+10.97%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
231.66K
-8.59%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
170.60K
+31.70%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
160.71K
+36.65%

常见问题

Clarivate PLC的前五大股东是谁?

Clarivate PLC 的前五大股东如下:Mr. Kenneth L. Cornick

有多少机构持有Clarivate PLC(CLVT)的股份?

截至2026Q1,共有545家机构持有Clarivate PLC的股份,合计持有的股份价值约为574.46M,占公司总股份的89.87%。与2025Q4相比,机构持股有所增加,增幅为-98628183.00。

哪个业务部门对Clarivate PLC的收入贡献最大?

在2026Q1,Subscription revenues业务部门对Clarivate PLC的收入贡献最大,创收1.61B,占总收入的65.39%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有